NEW YORK, June 25 – Epoch Biosciences has licensed technology from Applied Biosystems for SNP detection and gene expression assays, the company said Monday. 

The technology, for using non-cleavable fluorescent self-quenching probes in hybridization assays, will be incorporated into the company’s assays for measuring gene expression and detecting SNPs. The company plans to release the first version of the assays this summer, in the launch of Epoch’s first product for the commercial market.